Commodore Capital LP Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$1.4T
Holdings
31
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (31 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRUSMERUS N V | 4,472,840 | $188.3B | 13.87% | |
| 2 | NUVLNUVALENT INC | 1,855,000 | $131.6B | 9.69% | |
| 3 | ELVNENLIVEN THERAPEUTICS INC | 4,675,000 | $92.0B | 6.78% | |
| 4 | SLNOSOLENO THERAPEUTICS INC | 1,150,000 | $82.2B | 6.05% | |
| 5 | XENEXENON PHARMACEUTICALS INC | 2,325,000 | $78.0B | 5.75% | |
| 6 | ALKSALKERMES PLC | 1,950,000 | $64.4B | 4.74% | |
| 7 | AGIOAGIOS PHARMACEUTICALS INC | 2,185,000 | $64.0B | 4.72% | |
| 8 | PCVXVAXCYTE INC | 1,650,000 | $62.3B | 4.59% | |
| 9 | VERAVERA THERAPEUTICS INC | 2,561,782 | $61.5B | 4.53% | |
| 10 | TCE2CELLDEX THERAPEUTICS INC NEW | 3,200,000 | $58.1B | 4.28% | |
| 11 | SRRKSCHOLAR ROCK HLDG CORP | 1,745,000 | $56.1B | 4.13% | |
| 12 | COGTCOGENT BIOSCIENCES INC | 8,892,816 | $53.3B | 3.93% | |
| 13 | VRDNVIRIDIAN THERAPEUTICS INC | 3,600,000 | $48.5B | 3.58% | |
| 14 | NRIXNURIX THERAPEUTICS INC | 3,978,907 | $47.3B | 3.48% | |
| 15 | CNTACENTESSA PHARMACEUTICALS PLC | 2,367,578 | $34.0B | 2.51% | |
| 16 | SYRESPYRE THERAPEUTICS INC | 1,988,084 | $32.1B | 2.36% | |
| 17 | PHVSPHARVARIS N V | 1,911,433 | $30.0B | 2.21% | |
| 18 | BRD1EURMIND MEDICINE MINDMED INC | 4,525,000 | $26.5B | 1.95% | |
| 19 | SLDBSOLID BIOSCIENCES INC | 5,825,000 | $21.6B | 1.59% | |
| 20 | DRUGBRIGHT MINDS BIOSCIENCES INC | 500,000 | $18.0B | 1.33% | |
| 21 | CRDFCARDIFF ONCOLOGY INC | 5,384,616 | $16.9B | 1.25% | |
| 22 | ORKAORUKA THERAPEUTICS INC | 1,419,714 | $14.6B | 1.07% | |
| 23 | IKTINHIBIKASE THERAPEUTICS INC | 5,344,432 | $11.7B | 0.86% | |
| 24 | ORICORIC PHARMACEUTICALS INC | 2,000,000 | $11.2B | 0.82% | |
| 25 | APGEAPOGEE THERAPEUTICS INC | 290,000 | $10.8B | 0.80% | |
| 26 | NGNENEUROGENE INC | 925,000 | $10.8B | 0.80% | |
| 27 | TYRATYRA BIOSCIENCES INC | 950,000 | $8.8B | 0.65% | |
| 28 | —PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7.7B | 0.57% | |
| 29 | CELCCELCUITY INC | 695,650 | $7.0B | 0.52% | |
| 30 | VTGNVISTAGEN THERAPEUTICS INC | 1,575,000 | $3.9B | 0.29% | |
| 31 | AVTXAVALO THERAPEUTICS INC | 483,000 | $3.9B | 0.29% |